27 results
8-K
EX-99.1
AXLA
Axcella Health Inc.
1 Nov 22
Axcella Reports Third Quarter Financial Results and Provides Business Update
8:02am
EMMPACT trial in NASH.
Long COVID is a persistent and growing challenge of the pandemic, affecting an estimated one hundred million patients
424B5
z744w5z18vkgf3hx
13 Oct 22
Prospectus supplement for primary offering
7:55am
8-K
EX-99.1
sm7sw5mxmlh5nd4w q8j
2 Aug 22
Axcella Announces Highly Promising Results from Phase 2a Placebo Controlled Clinical Trial for Long COVID
4:06pm
8-K
EX-99.1
iysx2v23
26 May 22
Axcella Announces Completion of Enrollment of Clinical Trial for Long COVID and Has Prioritized its Clinical Portfolio
8:12am
424B5
x6ucnt t7vbl0oky5dsa
16 Mar 22
Prospectus supplement for primary offering
8:00am
8-K
EX-99.1
2qksoz0x122jw69
12 Nov 20
Axcella Reports Third Quarter 2020 Financial Results and Provides Business Update
7:47am